Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index
NCT05946122
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
106
Enrollment
OTHER
Sponsor class
Conditions
Renal Protection
Interventions
DRUG:
Atorvastatin 40 Mg Oral Tablet
DRUG:
placebo drug
Sponsor
Minia University